Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Loan Update

30 Apr 2014 12:00

RNS Number : 9054F
Fitbug Holdings PLC
30 April 2014
 



Fitbug Holdings Plc / Epic: FITB.L / Index: AIM / Sector: Leisure

30 April 2014

Fitbug Holdings Plc ('Fitbug' or 'the Company')

Agrees extension of all loans to mid 2015 and secures additional £1 million loan on attractive terms

Legal action against Fitbit on course for court decision in 2015.

 

Fitbug Holdings Plc, the AIM listed provider of online personal health and well-being services, is pleased to announce that it has agreed that the repayment date of all loans to the Company from NW1 Investments Limited and Kifin Limited, a Kirsh Group subsidiary, be extended to 31 July 2015. Other terms remain unchanged including the interest rate which remains at 5%.

 

The Company is also pleased to announce that it has agreed a further £1 million loan ('the Loan') from NW1 Investments Limited ('Loan Holder'). The Loan is repayable by 31 July 2015 and will accrue interest at 5% per annum, payable on a quarterly basis. NW1 Investments Limited is a company in which the family of David Turner and Allan Fisher, both directors of Fitbug, have a material interest.

 

The independent directors of the Company, being Fergus Kee, Malcolm Fried, Paul Landau, Ann Jones, Geoffrey Simmonds and Andrew Brummer, consider, having consulted with Cantor Fitzgerald Europe, that the terms of the Loan are fair and reasonable in so far as shareholders are concerned.

 

The Company's legal action against Fitbit alleging trademark infringement, as well as unfair competition and unfair business practices, continues to progress and is scheduled to go to trial in the U.S. District Court for the Northern California in early 2015.

 

Fergus Kee, Chairman of Fitbug said, "This term extension on existing loans and the additional loan capital, both on attractive terms, significantly strengthens the Company's financial position at a time of strongly growing demand for wearable technology. We have an exciting pipeline of business ahead and we look forward to developing this and continuing our investment into both our sales strategy and product."

 

**ENDS**

 

For further information contact:

 

Paul Landau/Andrew Brummer

Fitbug Holdings Plc

020 7449 1000

Mark Percy/Catherine Leftley

Cantor Fitzgerald Europe

020 7894 7000

Claire Louise Noyce / William Lynne

Hybridan LLP

020 7947 4350 / 020 7947 4361

Elisabeth Cowell/Charlotte Heap

St Brides Media & Finance Ltd

020 7236 1177

 

 

Notes

 

Fitbug is a leading provider of online health and well-being services to help individuals to improve their lifestyles by making realistic changes to their daily routine. It combines activity tracking devices, which download to the Fitbug app and fitbug.com to provide an understanding of each user's daily activity achievements, with mobile and web technology providing users with personalised weekly activity and nutrition targets, feedback, advice and encouragement.

 

Key market sectors and distribution channels include retail, health insurance and rewards providers, workplace health programmes fitness operators and consumers. Increasingly, Fitbug's platform acts as the driving force behind third party services such as white label sites, activity driven games and challenge microsites and rewards programmes. The Company's main focus is now on building strategic partnerships with organisations that can integrate Fitbug into their own service/product offerings or resell to their customer base. The Company has operations in the UK, Australia and Asia, with the United States remaining the primary market. For more information, visit www.fitbug.com.

 

The Fitbug business was founded by Paul Landau, CEO of Fitbug Limited. Fergus Kee, Chairman of the Company is the former Managing Director of Bupa's £2.1 billion turnover UK and North American Division.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCIMMMTMBMJBFI
Date   Source Headline
22nd Apr 20217:00 amRNSAnnual General Meeting Statement
7th Apr 20214:41 pmRNSSecond Price Monitoring Extn
7th Apr 20214:36 pmRNSPrice Monitoring Extension
31st Mar 20216:11 pmRNSPosting of Annual Report & Accounts, Notice of AGM
26th Mar 20217:00 amRNSPreliminary Results for the y/e 31 December 2020
12th Feb 202110:00 amRNSBidstack teams up with Moat by Oracle
2nd Feb 20219:05 amRNSSecond Price Monitoring Extn
2nd Feb 20219:00 amRNSPrice Monitoring Extension
1st Feb 20219:05 amRNSSecond Price Monitoring Extn
1st Feb 20219:00 amRNSPrice Monitoring Extension
1st Feb 20217:00 amRNSTrading Update and Directorate Change
21st Jan 202111:05 amRNSSecond Price Monitoring Extn
21st Jan 202111:00 amRNSPrice Monitoring Extension
6th Jan 20212:05 pmRNSSecond Price Monitoring Extn
6th Jan 20212:00 pmRNSPrice Monitoring Extension
6th Jan 202111:05 amRNSSecond Price Monitoring Extn
6th Jan 202111:00 amRNSPrice Monitoring Extension
4th Jan 20214:41 pmRNSSecond Price Monitoring Extn
4th Jan 20214:36 pmRNSPrice Monitoring Extension
4th Jan 20212:06 pmRNSSecond Price Monitoring Extn
4th Jan 20212:00 pmRNSPrice Monitoring Extension
4th Jan 202111:05 amRNSSecond Price Monitoring Extn
4th Jan 202111:00 amRNSPrice Monitoring Extension
23rd Dec 20205:15 pmRNSBlock Listing Six Monthly Return
21st Dec 202011:00 amRNSPrice Monitoring Extension
17th Dec 20209:05 amRNSSecond Price Monitoring Extn
17th Dec 20209:00 amRNSPrice Monitoring Extension
17th Dec 20207:00 amRNSTrading Update
4th Dec 20204:41 pmRNSSecond Price Monitoring Extn
4th Dec 20204:36 pmRNSPrice Monitoring Extension
16th Nov 20202:40 pmRNSExercise of Warrants, Issue of Equity and TVR
11th Nov 20202:51 pmRNSExercise of Warrants, Issue of Equity and TVR
29th Oct 20201:20 pmRNSExercise of Warrants and Total Voting Rights
27th Oct 20208:38 amRNSBlock Listing Six Monthly Return
2nd Oct 20204:35 pmRNSPrice Monitoring Extension
24th Sep 202011:05 amRNSSecond Price Monitoring Extn
24th Sep 202011:00 amRNSPrice Monitoring Extension
24th Sep 20209:05 amRNSSecond Price Monitoring Extn
24th Sep 20209:00 amRNSPrice Monitoring Extension
23rd Sep 20204:40 pmRNSSecond Price Monitoring Extn
23rd Sep 20204:35 pmRNSPrice Monitoring Extension
15th Sep 202011:05 amRNSSecond Price Monitoring Extn
15th Sep 202011:00 amRNSPrice Monitoring Extension
15th Sep 20207:00 amRNSExclusive Agreement with Ubisoft for Hyper Scape
19th Aug 20204:41 pmRNSSecond Price Monitoring Extn
19th Aug 20204:35 pmRNSPrice Monitoring Extension
18th Aug 20204:40 pmRNSSecond Price Monitoring Extn
18th Aug 20204:35 pmRNSPrice Monitoring Extension
18th Aug 20207:00 amRNSInterim Results
17th Aug 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.